Skip to main content
. Author manuscript; available in PMC: 2021 May 13.
Published in final edited form as: J Diet Suppl. 2020 May 13;17(5):543–560. doi: 10.1080/19390211.2020.1761506

Table 3.

Gene expression in colon after 2 weeks of gavage with CRCE.

Colon 2-weeks
Mouse Human Function Vehicle 61.5 mg/kg 184.5 mg/kg 615 mg/kg
Ccl1 CCL1 C-C motif chemokine ligand 1 1.00 ± 0.16 1.69 ± 0.27 4.47 ± 1.17A 3.61 ± 1.34
Cd14 CXCL1 C-X-C motif chemokine ligand 1 1.00 ± 0.07 1.26 ± 0.17 1.23 ± 0.11 2.81 ± 0.28AB
Cxcl1 CD14 Monocyte differentiation antigen CD14 1.00 ± 0.21 2.80 ± 0.62A 2.67 ± 0.54A 5.57 ± 1.60AB
Cxcl2** CXCL2 C-X-C motif chemokine ligand 2 1.00 ± 0.01 7.32 ± 1.23A 97.33 ± 34.23 275.7 ± 110.5
Fas FAS Fas cell surface death receptor 1.00 ± 0.12 1.06 ± 0.12 1.46 ± 0.08AB 0.97 ± 0.09
Fasl* FASLG Fas ligand
Icam1 ICAM1 Intercellular adhesion molecule 1 1.00 ± 0.08 1.35 ± 0.09A 2.29 ± 0.31 AB 2.76 ± 0.33 AB
Il1a IL1A Interleukin 1 alpha 1.00 ± 0.25 2.14 ± 0.40 4.64 ± 0.74AB 3.51 ± 0.55A
Il1b IL1B Interleukin 1 beta 1.00 ± 0.14 1.57 ± 0.31 3.34 ± 0.94 3.31 ± 0.95
Il2 IL2 Interleukin 2 1.00 ± 0.11 1.25 ± 0.19 1.62 ± 0.14A 1.29 ± 0.27
Il4* IL4 Interleukin 4
Myd88 MYD88 MYD88 innate immune signal transduction adaptor 1.00 ± 0.13 1.05 ± 0.04 1.11 ± 0.03 1.09 ± 0.04
Tlr2 TLR2 Toll like receptor 2 1.00 ± 0.13 0.90 ± 0.15 1.57 ± 0.16A 0.94 ± 0.24
Tlr4 TLR4 Toll like receptor 4 1.00 ± 0.18 1.12 ± 0.15 0.98 ± 0.09 1.03 ± 0.11
Tnf TNF Tumor necrosis factor 1.00 ± 0.13 2.22 ± 0.45A 2.38 ± 0.39A 1.80 ± 0.40

Data presented at mean fold change from respective vehicle ± SEM (n = 3–6). *, not expressed (cells empty). Gene expression values between vehicle and each dose were compared with a t-test with Welch’s correction, if needed for unequal variances(A, significant comparison), and a one-way ANOVA or Kruskal-Wallis test (if failed equal variance test), followed by a multiple comparisons test, using a Bonferroni or Dunn’s correction, of each dose versus vehicle (**, significant ANOVA or Kruskall-Wallis without significant comparison; B, significant comparison).